Recruiting Breast Cancer Studies in Bensalem
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
The purpose of this clinical study is to learn about the safety and effects of the study medicine (called disitamab vedotin) for the possible treatment of people with breast cancer that is hard to tre...
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
This clinical trial is evaluating tucatinib in combination with Doxil in participants with human epidermal growth factor 2 positive (HER2+) locally advanced or metastatic breast cancer. The main goals...
About Breast Cancer Clinical Trials in Bensalem
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in Bensalem, PA. These studies are seeking a combined 136 participants. Research is being sponsored by Pfizer, SCRI Development Innovations, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Bensalem — FAQ
Are there breast cancer clinical trials in Bensalem?
Yes, there are 2 breast cancer clinical trials currently recruiting in Bensalem, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Bensalem?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bensalem research site will contact you about next steps.
Are clinical trials in Bensalem free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bensalem studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in Bensalem are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov